Garheng Kong - 05 Oct 2021 Form 3 Insider Report for Xeris Biopharma Holdings, Inc. (XERS)

Role
Director
Signature
/s/ Beth Hecht as Attorney-in-Fact
Issuer symbol
XERS
Transactions as of
05 Oct 2021
Net transactions value
$0
Form type
3
Filing time
05 Oct 2021, 17:18:57 UTC
Previous filing
05 Oct 2021
Next filing
04 Nov 2021

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney